Biopolymers are macromolecules that are divided into three classes: polysaccharides (chitosan, dextran, cyclodextrins, pectin, hyaluronan, guar gum, sodium alginate, cellulose, and starch), proteins (gelatin, albumin, and milk proteins), and nucleic acids (161). To use BBN as a drug delivery vehicle, it is critical to control particle size, the charge on the particle, and specific surface area (161, 162). BBN can provide the high possibility of transporting bioactive compounds to the site of action, which has attracted more attention from chemists, biologists, and pharmaceutical scientists (163). The primary goal of BBN is to elevate the drug’s water solubility, stability, reduce destruction, improve bioavailability, bioactivity, biodegradability, lower toxicity, and flexibility of gel formation (164). Spray drying, electrospray, high–pressure homogenization, supercritical fluid, electrospinning, emulsion–diffusion, reverse micelle, and emulsion – droplet coalescence are just a few of the fabrication methods to engineer BBN (165).

Biopolymer-based biomaterials were studied for use in accelerated diabetic wound healing. Cashew gum (CG) based bio nanocomposite was used as a platform for trials. Crude samples of cashew gum exudate were collected from Anacardium occidentale L. for the trial, cashew gum-coated prussian blue nanoparticles (PBNPs) were prepared in situ and characterized. CG coating decreased the size of the spherical PBNPs from 50 to 5 nm and the crystallinity of PBNP’s core was increased. The use of CG polysaccharides was found to be an excellent and effective strategy for covering and controlling the size, shape, and crystallinity of prussian blue via an in-situ synthesis (166). Sebak et al. created noscapine-loaded nanoparticles (NPs) with human serum albumin (HSA) for targeted administration and tested them on SK-BR-3 breast cancer cells using the pH coacervation technique. The results showed that noscapine NPs were substantially more effective than free noscapine in lowering SK-BR-3 cell viability (167). Cationic chitosan (CS)- and anionic sodium alginate (Alg)-coated PLGA NPs loaded with revasterol have been developed by the nanoprecipitation technique (168). For six months, the nanoparticles can inhibit trans isoform breakdown and revasterol escape from the carrier.

Liposomes are formed from combining cholesterol with phospholipids (128). They shield the enclosed medication from enzyme and other inhibitor activity. They can transport any medication via endocytosis and are hence commonly employed for compounds that cannot pass biological membranes. Their disadvantages involve instability, identification by the immune system, and phagocytosis. Conjugation with polyethylene glycol (PEGylation) can shield them from phagocytosis, making them particularly efficient in carrying anticancer medicines (169). Using a thin-film hydration and extrusion method, Lu et al. prepared folic acid conjugated PEGylated liposomes of vincristine for multidrug-resistant cancer therapy and evaluated their cytotoxicity on KBv200 carcinoma cell line and also performed in vivo antitumor efficacy studies (tumor growth inhibition and apoptosis assessment studies by TUNEL) (170). The IC50 of the PEGylated folic acid-linked vincristine liposomes was 23.99 nM, compared to 1.10 nM for free vincristine and 363.08 nM for PEG-LS/vincristine. In vivo tests revealed that folic acid conjugation greatly improved the antitumor activity of the PEGylated liposomes of vincristine, as well as a higher apoptotic index was captured in the TUNEL assay (24.1 vs. 14.4). In another research study, Liposomal ursolic acid showed improved anticancer activity for breast cancer and prostate cancer cell lines than free ursolic acid (171). Recently, a cationic liposome encapsulating hydroxycamptothecin and 5-aminolevulinic acid was administered along with chemo-sonodynamic therapy against metastatic lung cancer that has demonstrated a better apoptotic behavior (172). Moreover, a phase-1 study with 96 non-randomized participants was carried out to assess the effect of liposomal topotecan intravenous injection for the treatment of advanced solid lung tumors. Topotecan is the semi-synthetic derivative of the naturally obtained topoisomerase inhibitor, camptothecin, and the results are yet to be disclosed but the trial is reported to enter phase-2 study by the beginning of the year 2023 (NCT04047251). Inhalable liposomes are being developed and their preparation is studied for use in pulmonary diseases (173). Daunorubicin and cytarabine (vyxeos^®) were encapsulated in liposomes (Vyxeos^®, CPX‐351) for the treatment of adults with newly diagnosed, therapy‐related acute myeloid leukemia or acute myeloid leukemia with myelodysplasia related changes (NCT01696084). Vyxeos^® is an orphan drug and its clinical trial proved to be remarkable. A clinical study CLTR0310‐301 (also referred to as Study 301) was a phase III, multicenter, open‐label, randomized, trial of vyxeos^® (daunorubicin‐cytarabine) liposomal injection versus standard 3 + 7 daunorubicin and cytarabine in patients aged 60–75 years with untreated high‐risk (secondary) (173, 174). A recent clinical trial is investigating the efficacy and safety of paclitaxel liposome as first-line therapy in patients with advanced pancreatic cancer. The patients were given paclitaxel liposome 175 mg/m² intravenously every 3 weeks for 3 weeks until the disease recurrence. All five parameters, including overall response rate, overall survival, disease control rate, quality of life, and adverse events are examined (NCT04217096). Moreover, an open-label, phase-1 study on the use of liposomal irinotecan injection was carried out on 136 participants to study its effects on advanced breast cancer and evaluate its efficacy and safety (NCT04728035). Transfersomes are phosphatidylcholine-containing liposomes with an edge activator (175). Because of greater penetration, celecoxib loaded into transfersomes containing soy phosphatidylcholine combined with sodium deoxycholate was found to be a therapeutically efficient drug-delivery approach for the treatment of rheumatoid arthritis (176).

Niosomes are obtained through combining an alkyl or dialkyl polyglycerol-based nonionic surfactant and subsequent hydration in an aqueous environment. Because of their comparable construction, they are frequently employed as a replacement for liposomes (132). They are not toxic and restrict the action of drugs to specific locations. Niosomes have also been shown to be manipulable as a part of advanced drug delivery strategies and can deliver drugs via intravenous, transdermal, ocular, and pulmonary routes. Cancer therapy, gene therapy, and targeting medicine via the nasal route are some of the other uses for niosome based drug delivery. It is also used in immunological applications, such as a hemoglobin transporter, and for cosmetic reasons (177). Morusin-loaded niosomes have been produced for cancer therapy (178). Nanomorusin, unlike free morusin, was shown to be easily dispersible in aqueous environments. Morusin was shown to have an extraordinarily high drug entrapment efficiency (97%), regulated and prolonged release, and increased therapeutic effectiveness in cancer cell lines from four distinct lineages. A different research study evaluated the anticancer activity of niosomes containing both curcumin and methotrexate against colorectal cancer cell lines (179). The niosomal formulation showed more in vitro cell toxicity than their combination in free form. The anti-arthritic efficiency of luteolin (LT)-loaded niosomes made with different nonionic surfactants was tested in vitro and in vivo, with improved entrapment efficacy and higher transdermal flow across the rat skinned discharge. The cytotoxicity study showed a lesser IC50 value from LT-NVs than the pure LT (180). Thus, it can be concluded that LT-NVs are a natural alternative to synthetic drug in the treatment of lung cancer. The therapeutic purpose of niosomes is to deliver anticancer drugs, protein, peptide, and natural product delivery with improved bioavailability. Numerous experts are now intrigued by the delivery of natural compounds such as curcumin, which has low solubility and bioavailability (177). As a result, clinical trials with the combination of Curcuma longa L. and doxorubicin are underway (NCT04996004). Aside from curcumin, there are natural compounds called morusin that have powerful antibacterial, anti-inflammatory, and anticancer properties. Rahman et al. developed a formulation in which morusin is loaded with niosomes as a carrier, removing the barrier of low solubility and stability to target the specific cell (126). A study to evaluate the efficacy and safety of niosomal docetaxel lipid suspension compared to taxotere^® in triple-negative breast cancer patients (after failure to previous chemotherapy) was conducted (NCT03671044). In this randomized, open-label clinical trial, females 18-65 years of age were eligible to apply. The niosomal docetaxel lipid suspension was administered intravenously at three-week intervals at a dose of 75 mg/m². Patients received drug doses until disease progression and unacceptable toxicity occurred. This procedure was repeated with a 100 mg/m² dose of niosomal docetaxel lipid suspension. The trial’s primary goal is to compare the proportion of patients with the best overall response rate in niosomal docetaxel lipid suspension and taxotere^® (NCT03671044).

Micelles are lipid molecules that organize themselves in a spherical shape in aqueous solutions. They fluctuate in size from 10 to 100 nm and are generally quite narrow in terms of the size distribution (181). They can improve drug absorption and retention by shielding the drug from inactivation by its micellar environment. This system is made up of a core-shell structure with a lipophilic core and a shell made up of hydrophilic polymer blocks (182). The physicochemical properties of the drug and their position in the micelle influence their release. Certain physical stimuli, such as pH, temperature, ultrasound, and light can also promote drug release from the micelles in the targeted location (183). Micelles also provide an increased drug accumulation at the tumor site. Recently, doxorubicin delivery through covalent attachment with the hydrophobic portions of an amphiphilic block copolymer resulted in pH-regulated drug release (184). Paclitaxel, doxorubicin, 5-fluorouracil, 9-nitrocamptothecin, cisplatin, triptorelin, dexamethasone, and xanthone were all microencapsulated in poly lactic-co-glycolic acid (PLGA), polymerized lactic acid (PLA), and polycaprolactone (PCL) nanostructures with a micellar backbone (185). The medications are released to the target. Paclitaxel, for example, is encapsulated in polymeric micelles, which improves the systemic pyruvate kinase (PK) profile and interferes with drug-producing adverse effects such as neurotoxicity. It is USFDA approved and the formulation is marketed as Genexol^® PM (183). As a solution to breast cancer and better intracellular delivery of docetaxel, novel pH-triggered biocompatible polymeric micelles have been developed based on heparin–α-tocopherol conjugate. For this, the amphiphilic copolymer was synthesized by grafting α-tocopherol onto the heparin backbone by a pH-cleavable bond (186). The paclitaxel and cisplatin-loaded polymeric micelles in advance non-small cell lung cancer were evaluated as a comparative phase 2 study with 276 participants. The primary endpoint of this study is a response rate of up to 6 cycles to ensure that the overall anticancer response is achieved. The secondary outcome measure is overall survival over three years (NCT01023347). The safety results are satisfactory (data not available in the public domain) and they have started phase 3 studies (NCT02667743).

Magnetic microspheres are made up of microscopic supramolecular particles that are surrounded by capillaries. The primary goal of magnetic microspheres is to deliver drugs to the specific site of action that ultimately reduces the adverse effects. Magnetic microspheres are composed of tiny particles such as protein, silica, hydroxylapatite, magnetite (Fe₃O₄), maghemite (gamma Fe₂O₃), and synthetic polymers (143). The drug delivery is divided into two parts: spatial placement and temporal delivery of the drug (143). Magnetic microspheres cause pharmaceuticals to be released in a sustained manner rather than having a high bioavailability. Examples of magnetic microspheres-containing products are lupron depot^® and nutropin depot^® (187). Solvent evaporation, multiple emulsion techniques, phase separation emulsion polymerization, emulsion solvent extraction method, hot melt microencapsulation, and dispersion copolymerization are some methods for producing magnetic microspheres (183). It is used for the treatment of alveolar echinococcosis, a human helminthic disease caused by the larvae of Echinococcus multilocularis tapeworms. Treatment of this disease uses iron oxide magnetic particles. Spray-drying was used to create magnetic microspheres, which were then studied for their physicochemical features and dissolution profile. They were also tested for therapeutic effectiveness in both in vitro and in vivo systems. In vitro experiments in B16 melanoma cells found that using 30 M or 50 M sulforaphane with iron oxide in the polymeric carrier inhibited cell survival by around 13% -16%. In vivo data from C57BL/6 mice demonstrated that magnetic microspheres (located to the tumor site with the assistance of a powerful magnet) prevented 18% more tumor development than sulforaphane in solution (188). The magnetic microsphere of curcumin and doxorubicin demonstrated potential in vitro anticancer activity in cell viability and MTT cytotoxicity studies (189).

Nanoemulsions (NE) is a colloidal dispersion system, and one of their most essential functions is to act as a tool for increasing the bioavailability of poorly water-soluble medications (147, 148). They are composed of oil, water, amphiphile, phospholipid, alkyl polyglycosides, PEGylated fatty acid ester, and fatty alcohol. They are having mean droplet sizes less than 100 nm. The NE system has prolonged drug release, high solubility, higher skin permeability, more drug absorption, extremely low viscosity, less allergic response, and less drug degradation (190). Oral administration of the medication enhances bioavailability. The hydrophilic substances have higher permeability when administered subcutaneously or intramuscularly, and they are condensed into the lymphatic system (145). Over the last few years, NE has created novel systems such as Transcuto^® P, alkyl polyglycosides, etc. Natural herbal medications like rutin, genistein, brucea javanica oil, and coixenolide have been grated into NE for some applications. The antioxidant properties of Syagrus romanzoffiana (Cham.)Glassman, fruit O/W (oil in water) NE are assessed using the phase inversion technique (190). Paclitaxel nanoemulsion containing tocopherol as oil phase has been developed and evaluated for targeted cancer therapy that reached phase 3 clinical trials (NCT01620190) (191). The effects of eugenol nanoemulsion on pain were studied via a randomized double-blinded controlled cross-over trial (158). For the phonophoretic application of glucosamine and chondroitin in the treatment of knee chondropathies, nanoemulsion (nano CG) has been made and evaluated. Nano CG was previously applied in randomized and controlled clinical trials (192). In this experiment, patients in arm 1 receive nanoemulsion curcumin orally twice daily for up to 3 months. In arm 2, a placebo was administered orally twice daily for three months. This trial’s result was measured using the functional evaluation of cancer therapy (endocrine system inhibitor) to detect changes in aromatase inhibitor. This experiment is currently ongoing, however, it is not currently recruiting participants (NCT03865992). Plumbagin improves the efficacy of androgen deprivation therapy (ADT) in prostate cancer and it is now being evaluated in phase I clinical trial (193). A recent study found that plumbagin decreased PTEN-P2 driven tumor development only in castrated mice but not in intact animals, indicating that dihydrotestosterone (DHT) was generated in the testes and was primarily responsible for inhibiting prostate cell death (194). An oleic-acid-based nanoemulsion of plumbagin increases its antitumor efficacy (193). Nanoemulsion formulation of piplartine resulted in enhanced solubility, oral bioavailability, and anti-tumor efficacy of piplartine (195).

NPs are constructed of a range of materials, some of which are poisonous. Biodegradable materials are less harmful. NP systems are being investigated for a wide range of biological applications. NP protects the drug from enzymatic breakdown and allows for regulated drug release (196). Through adhesion to the capillary wall, NPs may improve the oral bioavailability of poorly soluble medicines and tissue absorption following parenteral administration. They may also improve drug transport across membranes. They are vulnerable to phagocytosis and endocytosis because of their hydrophobic surface, which is quickly covered with plasma proteins and taken up through the mononuclear phagocytic system (MPS) present in organs like the liver, spleen, and bone marrow (169).

Applying the ionic gelation process, berberine-loaded NPs were synthesized for anticancer potential (197). The rotary evaporated film ultrasonication process was used to create glycyrrhizic acid-loaded NPs (198). For testing therapeutic synergy in the ulcerative colitis (UC) model, pH-sensitive NPs of the curcumin-celecoxib combination were optimized. Its effectiveness was later validated in a UC model in rats, as per the tests (199). Gold NPs (AuNP) were created using a greener method that included digested Acorus calamus L. rhizome as a reductant and chloroauric acid as a starting material. The existence of a surface plasmon resonance (SPR) peak in the ultraviolet (UV)–visible spectral analysis revealed the formation of AuNP (200). Hexagonal antibacterial Zn_0.95Ag_0.05O (ZnAgO) NPs have been made using rosemary leaf extracts as a green chemistry method whose formation was confirmed by X-Ray Diffraction (XRD), Fourier transform infrared spectroscopy (FTIR), and UV–visible spectra (201). Clinical trials on magnetic fluid hyperthermia based on magnetic NPs were conducted and studied (NCT01411904). Nanoparticle role in photodynamic therapy for solid tumors has been studied via a clinical trial. The aim of the use of nanotechnology-based approaches as delivery tools for photosensitizer (PS) is to study the improvement in their cancer cellular uptake and their toxic properties, as well as the photodynamic therapy’s therapeutic impact (202). Potential anticancer activity is reported for apigenin-loaded PLGA nanoparticles against skin tumor in mice models (203). These nanoparticles showed ameliorative potentials in combating skin cancer and therefore have a greater prospect of use in the therapeutic management of skin cancer. Similarly, significant anticancer activity was reported against osteosarcoma cancer cells (MG63 and Saos-2 osteosarcoma cell lines) by formulating PLGA nanoparticles of etoposide and paclitaxel (204). The results of quercetin-loaded PLGA nanoparticle administration showed potential action against C6 glioma cells (205). It has demonstrated antioxidant properties and cellular oxidative resistance. The results showed that the improved batch (Qu1NPs) exhibited better cellular absorption at a lower IC50 value (29.9 gmL^-1) after 48 hours of incubation. The NPs may lessen resistance in brain cancers by lowering oxidative stress. A nano-phytocomposite consisting of phytochemical extract (BRM270) has cytotoxic potential against HepG2 human hepatoma cancer cells (206). A randomized, double-blind, placebo-controlled phase 2/3 study is now underway to assess the effectiveness of berberine hydrochloride against the development of new colorectal adenomas in 1,000 people who have a history of colorectal cancer (NCT03281096). A phase-2 trial is investigating the adverse effects of paclitaxel albumin-stabilized nanoparticle formulation for treating diseases such as fallopian tube cancer, primary peritoneal carcinoma, and recurrent ovarian carcinoma. The major goal of the experiment is to assess tumor response after each cycle for the first six months, as well as the frequency and severity of side effects seen. This research is open to people of all ages, however, only women are permitted (NCT00499252).

PEGylated surfactants are used in the production of lipid-based NPs. Lipids act as penetration enhancers of drugs. It also enhances drug solubility and diffusion from the lymphatic to the circulatory system. One of its applications is to improve central nervous system (CNS) bioavailability. They may be manufactured via quick, solvent-free, and scalable procedures. Some methods of preparation include nanoprecipitation, emulsification–solvent evaporation (ESE), or high-pressure homogenization (207). The microemulsion technology was used to create curcuminoid solid lipid NPs with the active component being curcuminoids. It has antioxidant and anticancer effects (199). Exocytosis of NPs is the step that details the cytosolic administration of therapeutic agents via NP carriers (208). Silymarin-loaded nanostructured lipid carrier (NLC) is the best example that has been used clinically to overcome low solubility, permeability, and bioavailability issues in hepatic diseases (126). Cardamom essential oil (CEO)-loaded NLCs have successfully been synthesized using food-grade lipids which include cocoa butter and olive oil. This modification led to a small size (90%), improved loading capacity (>25%), and provided good physical and chemical stability (126). Paclitaxel-loaded solid lipid nanoparticles showed better anticancer action in the murine breast cancer mice model (209). Several solid lipid nanoparticles have been created for the administration of cytotoxic medications such as doxorubicin, idarubicin, paclitaxel, camptothecan, 7-ethyl-10-hydroxy-20(S)-CPT, etoposide, flurodooxyuridine, and retinoic acid, as well as cholesterylbutyrate (210). The Ferula assafoetida seed oil (FSEO) -SLN nanoparticles inhibited the development of the human NT-2 cancer stem cell line significantly (211). They caused apoptosis by increasing the expression of TNF-, P21, and Cas3 genes. The FSEO-SLN inhibited angiogenesis in CAM tissue by reducing the length and quantity of blood vessels. As a result, it has the potential to be investigated as an effective anti-cancer agent. Similarly, Epigallocatechin-3-gallate (EGCG) SLN can improve EGCG bioavailability and stability and can be employed as an alternate approach for EGCG oral delivery (212). In the rat model, SLN-EGCG had neither acute or sub-chronic toxicity when compared to free EGCG.

Fullerenes, carbon nanotubes (CNTs), single-walled CNTs (SWCNTs), and graphene oxide (GO) are used in the production of carbon-based NPs. They have great antibacterial action and are utilized to limit energy metabolism, reduce or enhance O₂ absorption, and inhibit bacterial growth (152). They are 3–10 nm in diameter. Their interior structure is made up of graphite sheets that have been glued together to form a quasi-spherical nanoparticle. They are also utilized to make biosensors.

CNTs have been extensively investigated for their potential to deliver anticancer herbal compounds with better therapeutic effectiveness and safety (213). CNTs have been used in both therapeutic and environmental settings. Ocimum tenuiflorum L. (tulsi extract) containing photosynthesized silver nanoparticles (AgNP) loaded into emulsified multiwalled carbon nanotube (MWCNT) was developed for fertility analysis targeted to the intracellular part of the sperm cell. It was characterized by a spherical shape, 5–40 nm in size, and surface plasmon resonance imaging (SPR) at 430 nm (126). The total polyphenols content and antioxidant activity of Echinacea purpurea (L.)Moench. extracts were determined using glassy carbon electrodes modified with CNTs and chitosan (214). In a recent research study, carbon quantum dots of Echinops persicus extract demonstrated efficient antiradical activity (215). The biosynthesized silver nanoparticles of the leaf extract of Teucrium polium exhibited significant anticancer activity against the MNK45 human gastric cancer cell line (216).

Polymeric nanoparticles (PNs) are colloidal solid particles that are made up of various polymers such as chitosan, collagen, polylactic acid (PLA), PLGA, or other biodegradable polymers (146). PN enhances the bioavailability of the poorly soluble drugs by allowing the oral administration of the drug and increasing accumulation of the drugs at the site of action since the smaller size of the particle allows penetration into the capillaries and the cells (155). Methods of preparation of polymeric NPs include complex coacervation method, coprecipitation, salting out method, solvent displacement method, and solvent emulsification-diffusion method (185). Solvent evaporation, emulsification/solvent diffusion, nanoprecipitation, emulsification/reverse, and salting-out methods are all used to create nanospheres while nanoprecipitation is used to create nanocapsules. An organic phase is initially generated in the solvent evaporation process, which comprises a polar organic solvent in which the polymer is dissolved and the active component has incorporated either by dissolving or dispersion. Now PNs are approved by FDA for clinical use in the treatment of breast and pancreatic cancer and also some clinical trials are performed in many of the compounds such as ABI-008, ABI-009, and ABI-011(NCT04229004). The free radical process was used to create A. absinthium extract-loaded polymeric NPs (NVA-AA), which were efficient against breast cancer cell lines; MCF-7 and MDA MB-231 (217). Uncaria tomentosa (Willd. ex Schult.) DC. (UT) extracts have been shown to have promising antitumor activity for the enhancement and delivery, in which PCL and PLGA were employed for the generation of NPs loaded with UT extract by a single emulsion solvent evaporation method (218).

Dendritic packaging of bioactive agents allows for the separation of the active site, which has a structure similar to active sites in biomaterials (137). In addition, unlike most polymers, water-soluble dendrimers may be created by functionalizing their outer shell with charged species or other hydrophilic groups. Capsaicin-loaded dendrimers showed significant cytotoxicity on VERO cell line with an IC50 of 1.25 μg/mL and MCF-7 and HEp2 cell lines with an IC50 of 0.62 μg/mL (219). Polyamidoamine (PAMAM) dendrimers as oral drug delivery carriers for quercetin were evaluated. It was discovered to be in the nanometer range (100 nm) with a low polydispersity index. An in vitro investigation indicated a biphasic release pattern of quercetin, with an initial rapid release phase followed by a sustained release phase, and a pharmacodynamic analysis offered early proof of concept for the potential of quercetin-PAMAM complexes (220). Poly (propylene imine) dendrimer is also evaluated for different anticancer phytochemicals (221).

NSs are amorphous colloidal aqueous solutions with sizes ranging from 10 to 200 nm. Because they are tiny in size, they may be easily delivered orally, locally, and systemically, resulting in better bioavailability. They are made up of synthetic polymers such as PLA, polyglycolic acid (PGA), PLGA, and others (222). The main functions of the system include extending drug action due to delayed drug release, boosting bioavailability, enhancing drug entrapment, and boosting drug stability. It can also act against chemical degradation and minimize drug toxicity. Albumin NS, modified NS, starch NS, gelatin NS, polypropylene dextran NS, and polylactic acid NS are all examples of biodegradable NSs (223). Presently, two novel forms of NS have emerged: immune NS and magnetic NS. Both of these NSs are joined to form the immunomagnetic NS, and they considerably enhance drug targeting (222, 224). The targeting ability of the NS is currently being investigated in HeLa cells. Researchers have discovered that the C-phycocyanin (C-pc) NS is employed as a fluorescent producer. The intensity of fluorescence is higher in C-pc, indicating that it was directed at HeLa cells. Studies have revealed that the CD55 specific ligand peptide (CD55sp) is a potent anti-cancer factor. CD55sp is injected into the body of a mouse to assess the distribution of NSs, which are collected in the spleen, liver, and tumor. The liver and spleen metabolize the medication and start phagocytosis against malignancies (225). The pre-clinical trial such as oridonin (ORI)-loaded poly (D, L – lactic acid) (PLA) and polymer (RGD – Gly – Asp peptides) for the better antitumor actions (126). Another study created a near-infrared-responsive pharmacological system based on Au nanocages with Biotin–PEG–SH modification for the combination of doxorubicin and quercetin. The resulting nanocomplex have substantially more effective effects on MCF-7/ADR cell growth suppression under near-infrared irradiation. Furthermore, co-administration of doxorubicin and quercetin might significantly boost doxorubicin intracellular accumulation and dispersion in nuclei (226).

Nanocapsule (NC) is a colloidal dispersion system with a conventional core-shell structure, and the medicine is captured into the cavity of the central regions of the shell, which is surrounded by various polymer components such as polystyrene, titanium oxide (TIO₂), and silver (Ag). The NC platform has high drug encapsulation efficiency, low polymer content, and a core-shell that protects the medication from degradation elements such as pH and light (227). Nanoprecipitation, arc discharge method, emulsion–diffusion, double emulsification, interfacial polymerization, emulsion–coacervation, polymer coating, and layer–by–layer coating are some of the methods used to create nanocapsules. The layer–by–layer approach is used to improve the hydrophilicity of crystals, such as artemisinin (ART, Artemisia annua L) crystals, having good anticancer action. Herbal compounds have been encapsulated with polyelectrolytes for pharmacological self-release (150). There is one other method of preparation known as interfacial polymerization that yields a dispersion of aqueous core nanocapsules (228). Biogenic synthesis of PEG-enhanced Moringa oleifera Lam Ag nanocapsules was performed and its antibacterial activity was tested. The Ag nanocapsule (AgNs) formed had a single-phase cubic structure as seen under X-ray spectroscopy (229). Chitosan nanocapsules of tarragon essential oil were made, and had low cytotoxicity and long-lasting activity as a green nano-larvicide. Its cytotoxicity was checked on human skin lines (230). This system is already a clinical trial is completed such as an anti – HER2 mAb with paclitaxel and a mAb with doxorubicin (Doxo^®) (231). Mardani et al. discovered that curcumin nanomicelles might suppress lung metastasis and melanoma cell growth (B16 F10). The time and concentration of incubation are critical elements in imparting the potential activity of nanomicelle. Curcumin nanomicelles cause apoptosis even at low concentrations of 20 M. Curcumin also reduces angiogenesis and controls T Cell activation (232).

Metallic NPs (MNPs) are comprised of a metal core made of inorganic metal or metal oxide, which is generally surrounded by a shell also made of organic or inorganic material or metal oxide. Gold, silver, iron oxide, copper, zinc oxide, TiO₂, platinum, selenium, gadolinium, palladium, and cerium dioxide are some of the metals and metal oxides that are employed. Because NPs are poisonous to live cells, their manufacturing and usage in powder form are deemed risky. To address this issue, highly reactive MNPs can be encapsulated (233). Aqueous plant extracts were mixed with metal salt solutions to create MNPs. Secondary plant metabolites are continually involved in the redox process that produces environmentally favorable NPs. The initial indication for MNP production is detected as a color shift. UV visible spectroscopy can be used to track the development of the reaction. Because of the drawbacks of the other approaches, the biological synthesis of NPs is the ideal way for producing these MNPs (234). It is a one-step bio-reduction approach that requires less energy to synthesize eco-friendly NPs. The biochemical reaction of AgNO₃ reacting with plant broth results in the synthesis of AgNPs, according to the bio-reduction technique. Tribulus terrestris L extract was combined with various molar concentrations of silver nitrate solution to create eco-friendly AgNPs with distinct morphological properties. The methanolic extract of the Callicarpa maingayi Kjng and Gamble stem is employed in the manufacture of AgNPs and the formation of [Ag (Callicarpa maingayi)] + complex. The aldehyde group contained in the extract is mainly involved in the reduction of silver ions into metallic AgNPs (235). Piper nigrum L., leaves were stated to contain an important bioactive compound, involved in the NP synthesis by an eco-friendly method. Artemisia nilagirica(C.B.Clarke) Pamp., leaves were also used for the synthesis of NPs (224). These NPs are used because of their various properties. AgNPs are used as an antibacterial agent, wound dressing material, bone and tooth cement, and for water purification. MNPs are being used in a variety of fields, not simply in medicine and agriculture. MNPs are also employed in the manufacture of several bacteria, including Klebsiella pneumonia and Pseudomonas aeruginosa. It is also employed in the production of bioactive compounds and phytochemical constituents (236). In now a day the clinical trial is performed in some inorganic nanomaterials such as gold nanoparticles and silica nanoparticles (237). Folic acid surface modification improves the targetability of curcumin magnetic nanoparticles. Curcumin-loaded folate-grafted magnetic nanoparticles inhibit KB nasopharyngeal cancer cells and MCF-7 breast cancer cells significantly. The nanoparticles demonstrated targeted thermo-chemotherapy leading to apoptosis by a selective interaction with folate receptors, which are abundantly expressed in cancer cells, based on magnetic effect (238). The eupatorium-containing mPEG-b-PLGA-coated iron oxide nanoparticles were investigated towards prostate cancer cell lines (DU-145 and LNcaP). Furthermore, it exhibits increased apoptosis and reduced necrosis in the sub G1 phase, as well as enhanced cell populations, rendering it a suitable option for drug-resistant cancer treatment (239). The MTT experiment revealed that eupatorin-loaded Fe3O4@mPEG-b-PLGA nanoparticles significantly slowed the development of DU-145 and LNcaP cells, with IC50 values of 100 M and 75 M, respectively.

Inorganic nanoparticles are composed of silver, gold, iron oxide, silica, platinum, and gadolinium hydroxide (Gd(OH)₃). Magnetic (superparamagnetic iron oxide particles), nanoshell (dielectric silica core in thin gold metal shell), metallic, and ceramic (porous biocompatible substance) nanoparticles are its additional subclassifications based on the material used (240). They have good biocompatibility, can reduce cytotoxicity of medicines, increase the formation of reactive oxygen species (ROS), and have antibacterial action. In comparison to organic materials, these NPs are nontoxic, hydrophilic, biocompatible, and very stable. Inorganic nano-drug delivery methods such as mesoporous silica NPs, CNTs, layered double hydroxides, superparamagnetic iron oxide NPs, and calcium phosphate NPs have been developed as therapeutic uses in a variety of disorders, including neurodegenerative diseases. Magnetic NPs (MN) are employed in magnetic resonance imaging (MRI). Using zirconium oxide NPs, the antifungal activity of neem and aloe vera formulations was sustained and increased (241). In recent years, inorganic NPs have been synthesized and conjugated with tiny drugs for a variety of therapies. Inorganic NPs, which are mostly based on selenium, metallic chalcogenide, silicon, and carbon, are employed in oncotherapy (242). A pre-clinical trial of Anti-EGFR antibody cetuximab (C255) approved by FDA for the treatment of EGFR – positive colorectal cancer and palladium compound (TOOKAD) is a clinical trial by photo-dynamic therapy for the treatment of prostate cancer (65).